Maloberti Renaud Bertrand 4
4 · ENDRA Life Sciences Inc. · Filed Mar 30, 2022
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Award
Stock Options
2022-03-28+186,430→ 186,430 totalExercise: $0.38Exp: 2032-03-28→ Common Stock (186,430 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.